Back
Evolent Health Quote, Financials, Valuation and Earnings
Sponsored
EVH
Sponsored
AI DIVIDENDS: No. 1 Way to Collect Passive Income
Click here to get it for free.
Sell
32
EVH
Evolent Health
Last Price:
23.35
Seasonality Move:
3.14%
7 Day Trial
ALL ACCESS PASS
$
7
Beginner's Guide To Growing A Small Investment
Click here to download your free copy now!Evolent Health Price Quote
$23.35
Evolent Health Key Stats
Sell
32
Evolent Health (EVH)
is a Sell
Day range:
$23.05 - $24.57
52-week range:
$17.98 - $35.00
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
1.13
P/B ratio:
2.58%
Volume:
1.3M
Avg. volume:
1.7M
1-year change:
-4.42%
Market cap:
$2.7B
Revenue:
$2B
EPS:
$-0.94
How Much Does Evolent Health Make?
-
How Much Are Evolent Health's Sales Annually?
EVH Revenues are $2B -
How Much Profit Does Evolent Health's Make A Year?
EVH net income is -$113M
Is Evolent Health Growing As A Company?
-
What Is Evolent Health's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.38% -
What Is Evolent Health's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Evolent Health Stock Price Performance
-
Did Evolent Health Stock Go Up Last Month?
Evolent Health share price went down by -17.43% last month -
Did EVH's Share Price Rise Over The Last Year?
EVH share price fell by -4.42% over the past 1 year
What Is Evolent Health 52-Week High & Low?
-
What Is Evolent Health’s 52-Week High Share Price?
Evolent Health has traded as high as $35.00 over the past 52 weeks -
What Is Evolent Health’s 52-Week Low Share Price?
Evolent Health has traded as low as $17.98 over the past 52 weeks
Evolent Health Price To Free Cash Flow
-
Is Evolent Health Stock Overvalued?
Evolent Health is trading at a price to free cash flow ratio of 17.59 -
Is Evolent Health Stock Undervalued?
Evolent Health EV to Free Cash Flow ratio is 21.29 -
What Is Evolent Health’s Price Earnings Growth Ratio?
EVH PEG ratio is -0.72 -
Is Evolent Health Trading At A Premium To Earnings?
Evolent Health EV to EBIT ratio is 0.00
Is It Risky To Buy Evolent Health?
-
How Much Debt Does Evolent Health Have?
Total long term debt quarterly is $598.8M -
How Much Cash Does Evolent Health Have?
Cash and short term investments quarterly total is $101.3M -
What Is Evolent Health’s Book Value Per Share?
Book value per share is 9.19
Is Evolent Health Cash Flow Positive?
-
What Is EVH Cash Flow From Operations?
Cash flow from operations (TTM) is $176.2M -
What Is Evolent Health’s Cash Flow From Financing?
Cash flow from financing (TTM) is -$210.2M -
What Is Evolent Health’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$35.5M
Evolent Health Return On Invested Capital
-
Is Management Doing A Good Job?
EVH return on invested capital is -4.44% -
What Is Evolent Health Return On Assets?
ROA measures how assets are converting to revenues and is -2.84% -
What Is EVH Return On Equity?
ROE is a measure of profitability and is -6.94%
Evolent Health Earnings Date & Stock Price
-
What Is Evolent Health's Stock Price Today?
A single share of EVH can be purchased today for 23.35 -
What Is Evolent Health’s Stock Symbol?
Evolent Health trades on the nyse under the ticker symbol: EVH -
When Is Evolent Health’s Next Earnings Date?
The next quarterly earnings date for Evolent Health is scheduled on November 7, 2024 -
When Is EVH's next ex-dividend date?
Evolent Health's next ex-dividend date is November 1, 2024 -
How To Buy Evolent Health Stock?
You can buy Evolent Health shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Evolent Health Competitors
-
Who Are Evolent Health's Competitors?
Below is a list of companies who compete with Evolent Health or are related in some way:
Evolent Health Dividend Yield
-
What Is EVH Dividend Yield?
Evolent Health’s dividend yield currently is 0% -
What Is Evolent Health’s Payout Ratio?
Evolent Health’s payout ratio is -27.42% -
When Did Evolent Health Last Pay A Dividend?
The latest dividend pay date is November 1, 2024 -
What Is Evolent Health’s Dividend Per Share?
Evolent Health pays a dividend of $0.00 per share
Evolent Health Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | 18.48% |
Revenue: | 37.94% | 1.69% |
Analyst Recommendations
Buy Recommendations: | 11 |
---|---|
Hold Recommendations: | 0 |
Sell Recommendations: | 0 |
Price Target: | 41.75 |
Upside from Last Price: | 78.79% |